Concepedia

Author

Anne-Marie Halland

Roche (United Kingdom)

Also Known As

A.-M. Halland, A.M Halland, ANNE-MARIE HALLAND, Anne-Marie Halland

7

Publications

661

Citations

6

H-Index

0

Concepts

All Affiliations

Roche (United Kingdom)Cape Town Science CentreUniversidad Nacional Autónoma de MéxicoHospital General de MéxicoPomeranian Medical University
AH

About

Anne-Marie Halland is an author at Roche (United Kingdom).

Anne-Marie Halland

×

4

Publications

645

Citations

4

H-Index

YearCitations

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu

Joel M. Kremer, Ricardo Blanco, Marek Brzosko,

Arthritis & Rheumatism

2010

410

Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results

Roy Fleischmann, Anne-Marie Halland, Marek Brzosko,

The Journal of Rheumatology

2013

121

Musculoskeletal manifestations in hyperlipidaemia: a controlled study.

P Klemp, Anne-Marie Halland, F L Majoos,

Annals of the Rheumatic Diseases

1993

89

Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.

Joel M. Kremer, Ricardo Blanco, Anne-Marie Halland,

PubMed

2016

25

Page 1